Eqis Capital Management, Inc. Fulgent Genetics, Inc. Transaction History

Eqis Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $124,076 - $239,217	-2,489 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $192,399 - $261,345	2,489 New	2,489 $250,000
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $213,678 - $316,422	-2,854 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$66.8 - $100.45 $190,647 - $286,684	2,854 New	2,854 $263,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $613M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.